11 research outputs found

    Einfluss von Androgenen und Salzhaushalt auf die renale Mineralokortikoid- und Glukokortikoidrezeptor-Expression von orchiektomierten Wistar-Ratten

    Get PDF
    EinfĂŒhrung: Der Zusammenhang zwischen Salzlast, Niere und arterieller Hypertonie ist gut definiert. Neuere Erkenntnisse deuten auf eine entscheidende Interaktion des mineralokortikoiden und glukokortikoiden Systems in der Blutdruckregulation hin. DarĂŒber hinaus weisen Geschlechterunterschiede im Blutdruck auf eine modulierende Rolle von Androgenen hin. Wenig ist jedoch ĂŒber die Wechselwirkung zwischen Androgenen und dem Mineralokortikoidsystem bekannt. Die vorliegende Arbeit untersuchte die Wirkung der Androgensubstitution und des unterschiedlichen Salzstatus auf die renale Expression des Mineralokortikoid- (MR) - und Glukokortikoidrezeptors (GR). Methoden: MĂ€nnliche Wistar-Ratten im Alter von 8-10 Wochen wurden orchiektomiert und erhielten eine Niedrigsalz- (< 0,03 % NaCl, Leitungswasser) oder Hochsalz-DiĂ€t (4 % NaCl, 0,09 % NaCl Trinkwasser) fĂŒr 5 Wochen. ZusĂ€tzlich wurden sie entweder mit Placebo, Testosteronpropionat (Testo: 1 mg/ Tier) oder 5α-Dihydrotestosteron (DHT: 1 mg/ Tier) als tĂ€gliche subkutane Injektion fĂŒr 16 Tage behandelt (jede Gruppe n = 6). Außerdem wurde den Tieren der Androgenrezeptor (AR)-Antagonist Flutamid, der MR-Antagonist Spironolacton bzw. Placebo appliziert. Anschließend wurde der Blutdruck in vivo und Hormonwerte bei Dekapitation bestimmt. Im Fokus wurde die renale mRNA- und Proteinexpression von MR und GR nach Organentnahme untersucht. Ergebnisse: Die Natriumbelastung fĂŒhrte zur Verminderung der MR mRNA als auch Protein-Expression bei den natriumreich ernĂ€hrten Kontrolltieren. Dieser Effekt konnte durch Spironolacton aufgehoben werden. DHT rief eine Steigerung der MR mRNA Expression hervor, auch bei Tieren, bei denen der AR blockiert war. Interessanterweise fĂŒhrte die AR-Blockade durch Flutamid zu einer signifikanten Hochregulierung der MR mRNA bei Ratten mit einer HochsalzdiĂ€t. Bei den salzarm ernĂ€hrten Ratten hingegen konnte unabhĂ€ngig von der Androgenbehandlung die Verminderung der MR mRNA Expression durch Flutamid beobachtet werden. In Ă€hnlicher Weise wurde die GR mRNA Expression bei Ratten bei einer HochsalzdiĂ€t unterdrĂŒckt. Dieser Effekt wurde durch Spironolacton aufgehoben. Die GR mRNA Expression wurde durch DHT unabhĂ€ngig vom Salzstatus hochreguliert. Nach AR-Blockade war dieser Effekt weniger ausgeprĂ€gt. Flutamid fĂŒhrte zu einer Hochregulierung von GR mRNA bei den natriumreich ernĂ€hrten Ratten, wĂ€hrend in den natriumarm ernĂ€hrten Ratten eine Herunterregulation von GR mRNA unabhĂ€ngig von der Androgenbehandlung beobachtet werden konnte. Schlussfolgerung: Androgene erhöhen die renale MR und GR mRNA Expression in gleicher Weise. Außerdem reguliert Flutamid sowohl die renale MR als auch die GR mRNA Expression in AbhĂ€ngigkeit vom Salzstatus der DiĂ€t, aber unabhĂ€ngig von der Androgenbehandlung. Diese Daten bestĂ€tigen eine Wechselwirkung von Androgenen mit dem renalen Mineralokortikoidsystem und eine mögliche AR-unabhĂ€ngige Wirkung von Flutamid auf die Blutdruckregulation. Der GR ist bei der Aufrechterhaltung der Natrium- und Wasser-Homöostase bereits unter physiologischen Bedingungen beteiligt.Introduction: An essential link between salt loading, renal function and arterial hypertension is well defined. Furthermore, sex differences in blood pressure point to a modulating role of androgens. New insights suggest crucial interdependent actions of the mineralocorticoid and glucocorticoid system in blood pressure regulation. But little is known about the interaction between androgens and the mineralocorticoid system. This study examined the effect of androgen treatment and different salt status on renal mineralocorticoid (MR) and glucocorticoid receptor (GR) expression. Methods: Male Wistar rats aged 8-10 weeks were orchiectomized and put on a lowsalt (chow < 0.03 % NaCl, tap water) or high-salt diet (chow 4 % NaCl, water 0.09 % NaCl) for 5 weeks. They were treated with either placebo, testosterone propionate (Testo: 1 mg/ animal) or 5α-dihydrotestosterone (DHT: 1 mg/ animal) as a daily subcutaneous injection for 16 days (each group n = 6). In addition, the animals received the androgen receptor (AR) antagonist flutamide, the MR antagonist spironolactone or placebo, respectively. In vivo measurements were made for blood pressure and hormone levels measured after decapitation. Renal mRNA and protein expression of MR and GR were assessed after animal sacrifice. Results: Sodium loading led to a downregulation of MR mRNA in control animals. This effect was abolished by spironolactone. DHT caused an upregulation of MR mRNA, but also in animals where AR was blocked. Interestingly, AR blockade by flutamide led to a significant upregulation of MR mRNA in rats on a high-salt diet, whereas downregulation of MR mRNA by flutamide independent of androgen treatment could be seen in salt-restricted rats. Similarly, GR mRNA expression was suppressed in rats on a high-salt diet. This effect was abolished by spironolactone. GR mRNA expression was upregulated by DHT independent of the salt status. After AR blockade this effect was less pronounced. Flutamide itself led to an upregulation of GR mRNA in rats on a high-salt diet, whereas a downregulation of GR mRNA was seen in salt-restricted rats independent of androgen treatment. Conclusions: Androgens increase renal MR and GR mRNA expression equally. Furthermore, flutamide regulates both renal MR and GR mRNA expression depending on the salt status of the diet in orchiectomized rats, but irrespective of androgen treatment. These data reflect a crosstalk of androgens with the renal mineralocorticoid system and a possible AR-independent effect of flutamide on blood pressure regulation. GR contributes to maintenance of sodium and water homeostasis physiologically

    Effect of risk factors on the outcomes of COVID-19-infected intensive care patients: a single-center retrospective study

    Get PDF
    Background: To date, little attention has been paid to the impact of risk factors on the outcome of patients with coronavirus disease 2019 (COVID-19) hospitalized in the intensive care unit (ICU). This study was performed to examine the effects of risk factors on death among COVID-19 patients hospitalized in the ICU.&nbsp; Methods: From April 2020 to November 2020, data on 141 COVID-19-infected intensive care patients at 7 Air Force Hospital, Kanpur, were retrospectively retrieved. All analyses were performed using SPSS statistical software (SPSS Inc., Chicago, IL, USA, 15.0). Bivariate and multivariate logistic regression analysis was done to identify independent risk factors. A p-value &lt;0.05 was considered statistically significant. Results: Most of study population were males (69.5%) with mean age of 59.8 ± 17.5 years. Out of 141 patients, 60 (42.6%) patients had comorbidities and 81 (57.4%) patients had no comorbidities. ICU death rates were 46.1%. Bivariate logistic regression analysis revealed that male sex (OR:0.45;95%CI:0.21-0.94), diabetes mellitus (OR:2.96; 95%CI:1.16-7.54), coronary artery disease (OR:2.48;95%CI:0.83-7.37), chronic kidney disease (OR:0.13,95% CI:0.02-1.12), patients with one (OR:1.25,95%CI:0.54-2.86) or more than two comorbidities (OR:1.95,95%CI:0.81-4.70), and who required high flow oxygen therapy (OR:13.30,95%CI:5.81-30.43), non-invasive (OR: 0.10,95% CI:0.02-0.45) and invasive ventilators (OR:0.04,95%CI:0.02-0.09) all were associated with higher ICU death rates. Multivariable logistic regression found following independent risk factors for death: patients with one comorbidity (OR:0.10;95%CI:0.02-0.66), non-invasive ventilator (OR:0.005;95%CI:0.000-0.091), and invasive ventilator (OR:0.003;95%CI:0.000-0.032). Conclusion: Identification of risk factors is of utmost importance to reduce death in COVID-19 infected intensive care patients

    Stability Study of Molecularly Doped Semiconducting Polymers

    No full text
    Molecular doping of semiconducting polymers has emerged as a prominent research topic in the field of organic electronics, with new dopant molecules introduced regularly. FeCl3 has gained attention as a p-type dopant due to its low cost, availability, ability to dope high ionization energy copolymers, and its use as a dopant that can be used with anion exchange. Here, we use a combination of UV–vis–NIR spectroscopy, four-probe sheet resistance measurements, and X-ray absorption near-edge structure (XANES) spectroscopy to perform lifetime measurements to assess the stability of the doped polymers over time, which is crucial for evaluating the long-term performance and reliability of the doped films. We used gas chromatography–mass spectrometry (GCMS) to prove that FeCl3 can cause radical side reactions that damage the conjugated polymer backbone, leading to the degradation of the electronic properties. The rate of this degradation is orders of magnitude higher when the film is exposed to air. Anion exchange doping can reduce the [FeCl4]− concentration, but does not necessarily improve the doping lifetime because anion exchange electrolytes can serve as coreactants for the degradation reaction. By comparison, doping with (2,3,5,6-tetrafluoro-2,5-cyclohexadiene-1,4-diylidene)­dimalononitrile (F4TCNQ) as the reactive dopant results in lower initial conductivity, but the lifetime of the doped polymer is almost tripled as compared to that of FeCl3 doped polymer films. These findings highlight that the use of FeCl3 as a molecular dopant requires a cost-benefit analysis between higher initial doping levels and lower film stability
    corecore